Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Current Assets (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Current Assets for 7 consecutive years, with $83.4 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Current Assets fell 36.53% year-over-year to $83.4 million, compared with a TTM value of $83.4 million through Sep 2019, down 36.53%, and an annual FY2018 reading of $121.3 million, up 15.63% over the prior year.
  • Current Assets was $83.4 million for Q3 2019 at Larimar Therapeutics, down from $94.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $236.3 million in Q1 2015 and bottomed at $78.0 million in Q2 2018.
  • Average Current Assets over 5 years is $135.8 million, with a median of $121.3 million recorded in 2018.
  • The sharpest move saw Current Assets surged 61.98% in 2015, then crashed 36.53% in 2019.
  • Year by year, Current Assets stood at $188.1 million in 2015, then tumbled by 30.41% to $130.9 million in 2016, then dropped by 19.84% to $104.9 million in 2017, then rose by 15.63% to $121.3 million in 2018, then tumbled by 31.23% to $83.4 million in 2019.
  • Business Quant data shows Current Assets for LRMR at $83.4 million in Q3 2019, $94.0 million in Q2 2019, and $107.5 million in Q1 2019.